First Tracks Biotherapeutics, Inc. (TRAX)

NASDAQ: TRAX · Real-Time Price · USD

18.16

-0.84 (-4.42%)

At close: Apr 24, 2026, 4:00 PM EDT

18.20

+0.04 (0.22%)

After-hours: Apr 24, 2026, 7:57 PM EDT

TRAX Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	-166.09	-163.71	-106.15
Depreciation & Amortization	2.42	2.4	2.38
Loss (Gain) From Sale of Investments	-4.73	-10.31	-10.52
Stock-Based Compensation	32.3	26.83	18.39
Change in Accounts Payable	-5.31	17.81	8.39
Change in Other Net Operating Assets	-1.52	1.18	-5.49
Operating Cash Flow	-142.93	-125.81	-93
Capital Expenditures	-0.09	-0.36	-0.81
Investment in Securities	228.12	95.76	145.56
Investing Cash Flow	228.03	95.4	144.75
Issuance of Common Stock	30.01	117.52	-
Other Financing Activities	-	-	-87.09
Financing Cash Flow	30.01	117.52	-87.09
Net Cash Flow	115.12	87.12	-35.34
Free Cash Flow	-143.01	-126.16	-93.81
Levered Free Cash Flow	-82.76	-63.42	-
Unlevered Free Cash Flow	-82.76	-63.42	-
Change in Working Capital	-6.83	18.99	2.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.